Publication | Closed Access
Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors.
81
Citations
0
References
1998
Year
CytogeneticsGeneticsPathologyTumor BiologyMyeloid NeoplasiaHematological MalignancyOncologyHematologyChromosome 22Molecular OncologyCancer ResearchBalanced Chromosome AberrationsHealth SciencesDna-topoisomerase Ii InhibitorsCancer GeneticsCell BiologyChromatinChromosome DynamicsMedicine
Article Tools Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.1998.16.5.1897 Journal of Clinical Oncology - published online before print September 21, 2016 PMID: 9586907 Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors. J Pedersen-BjergaardxJ Pedersen-BjergaardSearch for articles by this author , M K AndersenxM K AndersenSearch for articles by this author , B JohanssonxB JohanssonSearch for articles by this author Show More Laboratory for Cancer Genetics and Cytogenetics, the Finsen Center, Rigshospitalet, the University Hospital of Copenhagen, Denmark. https://doi.org/10.1200/JCO.1998.16.5.1897 PDF "Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors.." Journal of Clinical Oncology, 16(5), pp. 1897–1898© 1998 by American Society of Clinical Oncology